Arzerra (ofatumumab) - Novartis, Genmab
Ofatumumab Therapy and Long-Term Seizure Outcomes of Patients With Relapsing Anti-NMDA Receptor Encephalitis. (PubMed, Ann Clin Transl Neurol) - Sep 26, 2026 - "Ofatumumab showed substantial improvement in long-term seizure outcomes in patients with relapsing anti-NMDA receptor encephalitis, particularly those presenting with seizures as a predominant clinical feature." 
Journal • CNS Disorders • Epilepsy • Immunology • Psychiatry
http://www.ncbi.nlm.nih.gov/pubmed/42788399
 
Jian Wang; MengJiao Li; Ping Kong
 
Sep 26, 2026
 
Prev Next